
The episode discusses misconceptions about retatrutide and its Phase 3 results in obesity medicine.
Today, I want to talk about one of the most common misconceptions surrounding retatrutide and the recent Phase 3 results released by Eli Lilly. If you've seen the headlines, you've probably read that participants lost over 70 pounds or nearly 30% of their body weight. Those results are absolutely impressive and represent one of the most significant advances we've seen in obesity medicine. But there's an important detail that often gets overlooked when people see those numbers. Those results did not happen in a few months. The average weight loss reported in the study occurred over approximately 80 weeks, about a year and a half, with some participants followed for up to two years. Read the Full Episode Transcript: https://pepties.com/retatrutide/ Related Links/Products Mentioned: Peptide Podcast Partners Page https://pepties.com/partners/ Buy Peptides online at BioLongevity Labs: Use our link and enter COUPON CODE: PEPTIDEPODCAST at checkout to receive 15% off your total order: https://go.biolongevitylabs.com/SH5C Momentous Supplements (we use Creatine, Vital Aminos, Whey Protein) https://crrnt.app/MOME/OqGQOxGA LMNT – More Salt, Not Less…
Host: The Peptide Queen
BioLongevity Labs, Momentous Supplements, LMNT, Thorne Supplements, Organifi, MitoZen
Organizations: Eli Lilly
Products: retatrutide
Explore listener stats, chart rankings, contacts and more on the The Peptide Podcast podcast page.